Nuritas and Professor Graeme Close Launch Clinical Study Evaluating Bioactive Peptides in Longevity and Healthy Aging

Liverpool John Moores University and Nuritas announced a research collaboration to study PeptiStrong® in adults aged 60–85, targeting functional strength, muscle health, and longevity. The update is supportive of Nuritas’ product and scientific validation agenda, but no financial metrics or trial outcomes were provided, implying limited immediate market impact.

Analysis

Liverpool John Moores University and Nuritas announced a research collaboration to study PeptiStrong® in adults aged 60–85, targeting functional strength, muscle health, and longevity. The update is supportive of Nuritas’ product and scientific validation agenda, but no financial metrics or trial outcomes were provided, implying limited immediate market impact.